| 08/01 | MODERNA : Pfizer And Moderna Ramp Up EU COVID Vaccine Prices- FT | RE |
| 07/30 | MODERNA : Most COVID-19 cases in Massachusetts outbreak among vaccinated, says C.. | RE |
| 07/30 | J&J Won't Be Held Liable For Illinois Woman's Death in Talc Case -- Reuters | DJ |
| 07/30 | UPTRAVI® Receives FDA Approval for Intravenous Use in Adult Patients with Pul.. | CI |
| 07/30 | ANALYST RECOMMENDATIONS : Amazon, Barclays, Comcast, Next, Pfizer... | |
| 07/29 | Exclusive - AstraZeneca exploring options for COVID-19 vaccine business - exe.. | RE |
| 07/29 | PFIZER : Goldman Sachs Adjusts Pfizer's Price Target to $48 From $44, Maintains .. | MT |
| 07/29 | PFIZER : SVB Leerink Adjusts Price Target on Pfizer to $49 From $47, Maintains M.. | MT |
| 07/29 | PFIZER : Morgan Stanley Adjusts Price Target on Pfizer to $45 From $42, Maintain.. | MT |
| 07/29 | PFIZER INC : Goldman Sachs gives a Neutral rating | MD |
| 07/29 | Eli Lilly, Kumquat Biosciences Form Cancer Collaboration | DJ |
| 07/29 | ASTRAZENECA : exploring options for COVID-19 vaccine business - executive | RE |
| 07/29 | Lilly, Incyte Get Emergency Use Authorization for Covid-19 Treatment as Monot.. | DJ |
| 07/29 | PFIZER INC : RBC sticks Neutral | MD |
| 07/29 | Rubius Therapeutics Taps Dannielle Appelhans as Chief Operating Officer | DJ |
| 07/29 | ROCHE : Morningstar Lowers Price Target on Roche, Maintains Buy Recommendation | MT |
| 07/29 | PRESS RELEASE : FDA accepts application for -3- | DJ |
| 07/29 | PRESS RELEASE : FDA accepts application for -2- | DJ |
| 07/29 | PRESS RELEASE : FDA accepts application for Roche's faricimab for the treatment .. | DJ |
| 07/29 | FDA Accepts Application for Roche’s Faricimab for the Treatment of Neovascula.. | CI |
| 07/29 | PRESS RELEASE : Data for Roche's Evrysdi(R) -2- | DJ |
| 07/29 | PRESS RELEASE : Data for Roche's Evrysdi(R) (risdiplam) published in New England.. | DJ |
| 07/28 | MODERNA : Pfizer says 2021 COVID-19 vaccine sales to top $33.5 billion, sees nee.. | RE |
| 07/28 | Pfizer on Pace for Highest Close Since December 2018 -- Data Talk | DJ |
| 07/28 | Pfizer Inc. Reports Earnings Results for the Second Quarter Ended July 4, 202.. | CI |
| 07/28 | Pfizer Inc. Raises Earnings Guidance for the Full Year 2021 | CI |
| 07/28 | XOMA Gets Orphan Drug Designation for Pancreatic Cancer Treatment | DJ |
| 07/28 | NOVARTIS AG : Sell rating from JP Morgan | MD |
| 07/28 | Legal wrangles hold up U.S. vaccine donations to India | RE |
| 07/28 | Tranche Update on Pfizer Inc.'s Equity Buyback Plan announced on December 14,.. | CI |
| 07/27 | Moderna says COVID-19 vaccine supply outside United States to slow down | RE |
| 07/27 | ROCHE : Societe Generale Lifts Price Target on Roche, Maintains Hold Recommendat.. | MT |
| 07/27 | NOVARTIS : Morgan Stanley Lowers Price Target on Novartis, Maintains Overweight/.. | MT |
| 07/27 | NOVARTIS AG : Gets a Buy rating from Morgan Stanley | MD |
| 07/27 | SINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon.. | RE |
| 07/27 | Artios raises USD153m in Series C financing | DJ |
| 07/26 | MODERNA : in talks with FDA to expand COVID-19 vaccine pediatric study | RE |
| 07/26 | MODERNA : FDA asks Pfizer and Moderna to expand COVID-19 vaccine pediatric studi.. | RE |
| 07/26 | MODERNA : At FDA's Urging, Pfizer-BioNTech And Moderna Are Expanding Studies Of .. | RE |
| 07/26 | GLAXOSMITHKLINE : BioNTech aims to develop mRNA-based malaria vaccine | RE |
| 07/26 | PRESS RELEASE : BioNTech Provides Update on Plans to Develop Sustainable Solutio.. | DJ |
| 07/26 | ASTRAZENECA : BioNTech aims to develop mRNA-based malaria vaccine | RE |
| 07/26 | ROCHE : Independent Research Lifts Price Target on Roche, Maintains Buy Recommen.. | MT |
| 07/26 | ASTRAZENECA : India to miss end-July vaccination target as Bharat Biotech lags | RE |
| 07/26 | ANALYST RECOMMENDATIONS : Casey's, D.R. Horton, Microsoft, Unilever, Veoneer... | |
| 07/26 | ASTRAZENECA : Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - study | RE |
| 07/23 | Big tech companies retake market reins with earnings on tap | RE |
| 07/23 | ARVINAS : Oppenheimer Adjusts Arvinas PT to $108 From $100, Maintains Outperform.. | MT |
| 07/23 | JOHNSON & JOHNSON : UBS Adjusts Johnson & Johnson's Price Target to $183 From $1.. | MT |
| 07/23 | ROCHE HOLDINGS AG : Credit Suisse reiterates its Neutral rating | MD |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
